Article Dans Une Revue Bailliè re s Best Practice and Research in Clinical Haematology Année : 2009

Interferon in chronic myeloid leukaemia: past and future.

Résumé

Imatinib has revolutionized the therapy of chronic myeloid leukaemia. However the complete eradication of leukaemic stem cells is still a matter of discussion. Interferon (IFN) has been used in the past with success. However the proportion of patients who achieved sustained complete cytogenetic response was small. Recently, in addition to its direct antineoplastic effect and immunomodulatory activity, IFN has been shown to stimulate the quiescent leukaemic stem cells. Thus there is now a rational for combining Imatinib and IFN. Large prospective phase III trials are in good progress to demonstrate in humans the usefullness of a combination therapy using Imatinib and IFN.

Domaines

Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-00441364 , version 1 (15-12-2009)

Licence

Identifiants

Citer

François Guilhot, Lydia Roy, Pierre-Jean Saulnier, Joëlle Guilhot. Interferon in chronic myeloid leukaemia: past and future.. Bailliè re s Best Practice and Research in Clinical Haematology, 2009, 22 (3), pp.315-29. ⟨10.1016/j.beha.2009.10.005⟩. ⟨inserm-00441364⟩
137 Consultations
3 Téléchargements

Altmetric

Partager

  • More